Korean Journal of Chemical Engineering

, Volume 28, Issue 2, pp 315–322 | Cite as

Solid forms of pharmaceuticals: Polymorphs, salts and cocrystals

  • Bipul Sarma
  • Jie Chen
  • Huai-Ying Hsi
  • Allan S. Myerson
Invited Review Paper

Abstract

Control and selection of the properties of active pharmaceutical ingredients is a crucial part of the drug development process. One major part of this process is the selection of an appropriate solid form. This review will discuss three major types of crystalline solids, polymorphs, salts and cocrystals and processes used to develop and find these forms.

Key words

Solid Forms Polymorphs Pharmaceutical Salts Cocrystals Design Screening Scale-up 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    J.W. Mullin, Crystallization, 4th Ed., Butterworth-Heinemann (2001).Google Scholar
  2. 2.
    L. Yu, G. A. Stephenson, C.A. Mitchell, C.A. Bunnell, S.V. Snorek, J. J. Bowyer, T. B. Borchardt, J.G. Stowell and S. R. Byrn, J. Am. Chem. Soc., 122(4), 585 (2000).CrossRefGoogle Scholar
  3. 3.
    M. R. Caira, In Design of Organic Solids, 198, 163 (1998).CrossRefGoogle Scholar
  4. 4.
    J. Bauer, S. Spanton, R. Henry, J. Quick, W. Dziki, W. Porter and J. Morris, Pharm. Res., 18(6), 859 (2001).CrossRefGoogle Scholar
  5. 5.
    D. J. Kempf, K. C. Marsh, J. F. Denissen, E. Mcdonald, S. Vasavanonda, C.A. Flentge, B. E. Green, L. Fino, C. H. Park, X. P. Kong, N. E. Wideburg, A. Saldivar, L. Ruiz, W. M. Kati, H. L. Sham, T. Robins, K. D. Stewart, A. Hsu, J. J. Plattner, J. M. Leonard and D.W. Norbeck, P. Natl. Acad. Sci., USA, 92(7), 2484 (1995).CrossRefGoogle Scholar
  6. 6.
    D. Law, S. L. Krill, E. A. Schmitt, J. J. Fort, Y. H. Qiu, W. L. Wang and W. R. Porter, J. Pharm. Sci., 90(8), 1015 (2001).CrossRefGoogle Scholar
  7. 7.
    J. Bernstein, Polymorphism in molecular crystals, Clarendon, Oxford (2002).Google Scholar
  8. 8.
    S. R. Byrn, Solid state chemistry of drugs, Academic, New York (1999).Google Scholar
  9. 9.
    W. Z. Ostwald, Phys. Chem., 22, 289 (1897).Google Scholar
  10. 10.
    J. Aaltonen, M. Alleso, S. Mirza, V. Koradia, K. C. Gordon and J. Rantanen, Eur. J. Pharm. Biopharm., 71(1), 23 (2009).CrossRefGoogle Scholar
  11. 11.
    S. L. Morissette, Ö. Almarsson, M. L. Peterson, J. F. Remenar, M. J. Read, A.V. Lemmo, S. Ellis, M. J. Cima and C. R. Gardner, Adv. Drug. Deliv. Rev., 56(3), 275 (2004).CrossRefGoogle Scholar
  12. 12.
    S. Mirza, I. Miroshnyk, J. Heinamaki, L. Christiansen, M. Karjalainen and J. Yliruusi, Aaps. Pharm. Sci., 5(2), 39 (2003).CrossRefGoogle Scholar
  13. 13.
    I. Miroshnyk, L. Khriachtchev, S. Mirza, J. Rantanen, J. Heinamaki and J. Yliruusi, Cryst. Growth Des., 6(2), 369 (2006).CrossRefGoogle Scholar
  14. 14.
    M. D. Hollingsworth, M. L. Peterson, K. L. Pate, B. D. Dinkelmeyer and M. E. Brown, J. Am. Chem. Soc., 124(10), 2094 (2002).CrossRefGoogle Scholar
  15. 15.
    S. L. Childs, L. J. Chyall, J. T. Dunlap, D. A. Coates, B. C. Stahly and G. P. Stahly, Cryst. Growth Des., 4(3), 441 (2004).CrossRefGoogle Scholar
  16. 16.
    B. A. Garetz, J. Matic and A. S. Myerson, Phys. Rev. Lett., 89(17), 175501 (2002).CrossRefGoogle Scholar
  17. 17.
    G. Ruecroft, D. Hipkiss, T. Ly, N. Maxted and P.W. Cains, Org. Proc. Res. Dev., 9(6), 923 (2005).CrossRefGoogle Scholar
  18. 18.
    M. D. Lang, J.W. Kampf and A. J. Matzger, J. Pharm. Sci., 91(4), 1186 (2002).CrossRefGoogle Scholar
  19. 19.
    A.Y. Lee, I. S. Lee, S. S. Dettet, J. Boerner and A. S. Myerson, J. Am. Chem. Soc., 127(43), 14982 (2005).CrossRefGoogle Scholar
  20. 20.
    I. S. Lee, A. Y. Lee and A. S. Myerson, Pharm. Res., 25(4), 960 (2008).CrossRefGoogle Scholar
  21. 21.
    A. Singh, I. S. Lee and A. S. Myerson, Cryst. Growth Des., 9(2), 1182 (2009).CrossRefGoogle Scholar
  22. 22.
    S. M. Berge, L. M. Bighley and D. C. Monkhouse, J. Pharm. Sci., 66, 1 (1977).CrossRefGoogle Scholar
  23. 23.
    P. H. Stahl, G. Wermuth, G. (Eds): Handbook of Pharmaceutical Salts; Properties, Selection and Use (International Union of Pure and Applied Chemistry), New York, Wiley-VCH (2002).Google Scholar
  24. 24.
    C.B. Aakeroy, M. E. Fasulo and J. Desper, Mol. Pharma., 4(3), 317 (2007).CrossRefGoogle Scholar
  25. 25.
    R. J. Bastin, M. J. Bowker and B. J. Slater, Org. Proc. Res. Dev., 4, 427 (2000).CrossRefGoogle Scholar
  26. 26.
    B. D. Anderson and K. P. Flora, in’The Practice of Medicinal Chemistry’, Ed. C.G. Wermuth, Academic Press Ltd. London, Chapter 34 (1996).Google Scholar
  27. 27.
    S. F. Kramer and G. L. Flynn, J. Pharm. Sci., 61, 1896 (1972).CrossRefGoogle Scholar
  28. 28.
    A. T. M. Serajuddin, P. C. Sheen, D. Mufson, D. F. Bernstein and M. A. Augustine, J. Pharm. Sci., 75, 492 (1986).CrossRefGoogle Scholar
  29. 29.
    S. Li, P. Doyle, S. Metz, A. E. Royce and A. T. M. Serajuddin, J. Pharma. Sci., 94(10), 2224 (2005).CrossRefGoogle Scholar
  30. 30.
    T. D. Gross, K. Schaab, M. Ouellette, S. Zook, J. P. Reddy, A. Shurtleff, A. I. Sacaan, T. Alebic-Kolbah and H. Bozigian, Org. Proc. Res. Dev., 11, 365 (2007).CrossRefGoogle Scholar
  31. 31.
    J. B. Dressman, P. Bass, W. A. Ritschel, D. R. Friend, A. Rubinstein and E. Ziv, J. Pharm. Sci., 82, 857 (1993).CrossRefGoogle Scholar
  32. 32.
    E. Redenti, L. Szente and J. Szejtli, J. Pharm. Sci., 90(8), 979 (2001).CrossRefGoogle Scholar
  33. 33.
    T. L. Russel, R. R. Berardi, J. L. Barnett, T. L. O’sullivan, J.G. Wagner and J. B. Dressman, Pharm. Res., 11, 136 (1994).CrossRefGoogle Scholar
  34. 34.
    P. L. Gould, Int. J. Pharm., 33, 201 (1986).CrossRefGoogle Scholar
  35. 35.
    C. C. Sun and D. J. Grant, AAPS, Pharm. Sci. Suppl., 1, S–174 (1999).Google Scholar
  36. 36.
    M. Gazda, R. J. Dansereau, D. J. Crail, D. H. Sakkab and M. M. Virgin, Pharm. Sci., 1, S403 (1998).Google Scholar
  37. 37.
    R. B. Hammond, R. S. Hashim, C. Ma and K. J. Roberts, J. Pharm. Sci., 95(11), 2361 (2006).CrossRefGoogle Scholar
  38. 38.
    S. N. Black, E. A. Collier, R. J. Davey and R. J. Roberts, J. Pharm. Sci., 96(5), 1053 (2007).CrossRefGoogle Scholar
  39. 39.
    L. R. Madivada, R. R. Anumala, G. Gilla, S. Alla, K. Charagondla, M. Kagga, A. Bhattacharya and R. Bandichhor, Org. Proc. Res. Dev., 13, 1190 (2009).CrossRefGoogle Scholar
  40. 40.
    A. Sallmann, Bottmingen, R. Pfister and B. Switzerland, US3558690 (1971).Google Scholar
  41. 41.
    R. Bucci, A. D. Magrì, A. L. Magrì and Fresenius, J. Anal. Chem., 362, 577 (1998).Google Scholar
  42. 42.
    J. Bradshaw, B. J. Price and J.W. Clitherow, GB1565966 (1980).Google Scholar
  43. 43.
    G. J. Durant, J. C. Emmett and C. R. Ganellin, US3950333 (1976).Google Scholar
  44. 44.
    H. Yasufumi, Y. Isao, I. Yoshio, T. Shinichi, I. Noriki, I. Yasuo and T. Masaaki, US4283408 (1981).Google Scholar
  45. 45.
    Ö. Almarsson and M. J. Zaworotko, Chem. Commun., 17, 1889 (2004).CrossRefGoogle Scholar
  46. 46.
    I. Miroshnyk, S. Mirza and N. Sandler, Expt. Opin. Drug Deliv., 6, 333 (2009).CrossRefGoogle Scholar
  47. 47.
    M. C. Etter, J. Phys. Chem., 95, 4601 (1991).CrossRefGoogle Scholar
  48. 48.
    C.C. Seaton, K. Chadwick, G. Sadiq, K. Guo and R. J. Davey, Cryst. Growth Des., 10, 726 (2010).CrossRefGoogle Scholar
  49. 49.
    S. L. Morissettea, Ö. Almarsson, M. L. Peterson, J. F. Remenar, M. J. Read, A.V. Lemmo, S. Ellis, M. J. Cima and C. R. Gardner, Adv. Drug Deliv. Rev., 56, 275 (2004).CrossRefGoogle Scholar
  50. 50.
    A. V. Trask and W. Jones, Top. Curr. Chem., 35, 3523 (2005).Google Scholar
  51. 51.
    K. Chadwick, R. Davey, G. Sadiq, W. Cross and R. Pritchard, Cryst. Eng. Comm., 11, 412 (2009).Google Scholar
  52. 52.
    S. J. Nehm, B. Rodríguez-Spong and N. Rodríguez-Hornedo, Cryst. Growth Des., 6, 592 (2006).CrossRefGoogle Scholar
  53. 53.
    J. F. Remenar, M. L. Peterson, P.W. Stephens, Z. Zhang, Y. Zimenkov and M. B. Hickey, Mol. Pharma., 4(3), 386 (2007).CrossRefGoogle Scholar
  54. 54.
    A.V. Trask, W. D. S. Motherwell and W. Jones, Cryst. Growth Des., 5(3), 1013 (2005).CrossRefGoogle Scholar
  55. 55.
    P. Vishweshwar, J. A. McMahon, J. A. Bis and M. J. Zaworotko, J. Pharm. Sci., 95, 499 (2006).CrossRefGoogle Scholar
  56. 56.
    S. L. Childs, L. J. Chyall, J. T. Dunlap, V. N. Smolenskaya, B. C. Stahly and G. P. Stahly, J. Am. Chem. Soc., 126(41), 13335 (2004).CrossRefGoogle Scholar
  57. 57.
    A. Bak, A. Gore, E. Yanez, M. Stanton, S. Tufekcic, R. Syed, A. Akrami, M. Rose, S. Surapaneni, T. Bostick, A. King, S. Neervannan, D. Ostovic and A. Koparkar, J. Pharm. Sci., 97(9), 3942 (2008).CrossRefGoogle Scholar
  58. 58.
    J. F. Remenar, S. L. Morissette, M. L. Peterson, B. Moulton, J. M. MacPhee, H. R. Guzmán and Ö. Almarsson, J. Am. Chem. Soc., 125(28), 8456 (2003).CrossRefGoogle Scholar
  59. 59.
    J. Galcera and E. Molins, Cryst. Growth Des., 9(1), 327 (2009).CrossRefGoogle Scholar
  60. 60.
    N. Shan and M. J. Zaworotko, Drug Discov. Today, 13(9–10), 440 (2008).CrossRefGoogle Scholar
  61. 61.
    N. Schultheiss and A. Newmanwill, Cryst. Growth Des., 9(6), 2950 (2009).CrossRefGoogle Scholar

Copyright information

© Korean Institute of Chemical Engineers, Seoul, Korea 2011

Authors and Affiliations

  • Bipul Sarma
    • 1
    • 2
  • Jie Chen
    • 1
  • Huai-Ying Hsi
    • 1
    • 2
  • Allan S. Myerson
    • 1
    • 2
  1. 1.Department of Chemical EngineeringMassachusetts Institute of TechnologyCambridgeUSA
  2. 2.Novartis-MIT Center for Continuous ManufacturingCambridgeUSA

Personalised recommendations